The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Veterinary Drugs-Global Market Insights and Sales Trends 2025
Synopsis
Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
The global Veterinary Drugs market size is expected to reach US$ 34770 million by 2029, growing at a CAGR of 5.5% from 2023 to 2029. The market is mainly driven by the significant applications of Veterinary Drugs in various end use industries. The expanding demands from the Chickens, Swine, Cattle and Others, are propelling Veterinary Drugs market. Treatment Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Vaccines segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 23%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Veterinary Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Veterinary Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Veterinary Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Veterinary Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Veterinary Drugs covered in this report include Zoetis Inc., Boehringer Ingelheim Animal Health, Merck Animal Health, Elanco, Bayer AG, Ceva Sante Animale S.A., Virbac SA, Vetoquinol SA and IDEXX Laboratories, Inc., etc.
The global Veterinary Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Zoetis Inc.
Boehringer Ingelheim Animal Health
Merck Animal Health
Elanco
Bayer AG
Ceva Sante Animale S.A.
Virbac SA
Vetoquinol SA
IDEXX Laboratories, Inc.
Covetrus, Inc.
Global Veterinary Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Veterinary Drugs market, Segment by Type:
Treatment Drugs
Vaccines
Others
Global Veterinary Drugs market, by Application
Chickens
Swine
Cattle
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Veterinary Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
The global Veterinary Drugs market size is expected to reach US$ 34770 million by 2029, growing at a CAGR of 5.5% from 2023 to 2029. The market is mainly driven by the significant applications of Veterinary Drugs in various end use industries. The expanding demands from the Chickens, Swine, Cattle and Others, are propelling Veterinary Drugs market. Treatment Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Vaccines segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 23%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Veterinary Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Veterinary Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Veterinary Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Veterinary Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Veterinary Drugs covered in this report include Zoetis Inc., Boehringer Ingelheim Animal Health, Merck Animal Health, Elanco, Bayer AG, Ceva Sante Animale S.A., Virbac SA, Vetoquinol SA and IDEXX Laboratories, Inc., etc.
The global Veterinary Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Zoetis Inc.
Boehringer Ingelheim Animal Health
Merck Animal Health
Elanco
Bayer AG
Ceva Sante Animale S.A.
Virbac SA
Vetoquinol SA
IDEXX Laboratories, Inc.
Covetrus, Inc.
Global Veterinary Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Veterinary Drugs market, Segment by Type:
Treatment Drugs
Vaccines
Others
Global Veterinary Drugs market, by Application
Chickens
Swine
Cattle
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Veterinary Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Veterinary Drugs
1.1 Veterinary Drugs Market Overview
1.1.1 Veterinary Drugs Product Scope
1.1.2 Veterinary Drugs Market Status and Outlook
1.2 Global Veterinary Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Veterinary Drugs Market Size by Region (2018-2029)
1.4 Global Veterinary Drugs Historic Market Size by Region (2018-2023)
1.5 Global Veterinary Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Veterinary Drugs Market Size (2018-2029)
1.6.1 North America Veterinary Drugs Market Size (2018-2029)
1.6.2 Europe Veterinary Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Veterinary Drugs Market Size (2018-2029)
1.6.4 Latin America Veterinary Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Veterinary Drugs Market Size (2018-2029)
2 Veterinary Drugs Market by Type
2.1 Introduction
2.1.1 Treatment Drugs
2.1.2 Vaccines
2.1.3 Others
2.2 Global Veterinary Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Veterinary Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Veterinary Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Veterinary Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Veterinary Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Veterinary Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Veterinary Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Veterinary Drugs Revenue Breakdown by Type (2018-2029)
3 Veterinary Drugs Market Overview by Application
3.1 Introduction
3.1.1 Chickens
3.1.2 Swine
3.1.3 Cattle
3.1.4 Others
3.2 Global Veterinary Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Veterinary Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Veterinary Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Veterinary Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Veterinary Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Veterinary Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Veterinary Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Veterinary Drugs Revenue Breakdown by Application (2018-2029)
4 Veterinary Drugs Competition Analysis by Players
4.1 Global Veterinary Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Drugs as of 2022)
4.3 Date of Key Players Enter into Veterinary Drugs Market
4.4 Global Top Players Veterinary Drugs Headquarters and Area Served
4.5 Key Players Veterinary Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Veterinary Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Zoetis Inc.
5.1.1 Zoetis Inc. Profile
5.1.2 Zoetis Inc. Main Business
5.1.3 Zoetis Inc. Veterinary Drugs Products, Services and Solutions
5.1.4 Zoetis Inc. Veterinary Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Zoetis Inc. Recent Developments
5.2 Boehringer Ingelheim Animal Health
5.2.1 Boehringer Ingelheim Animal Health Profile
5.2.2 Boehringer Ingelheim Animal Health Main Business
5.2.3 Boehringer Ingelheim Animal Health Veterinary Drugs Products, Services and Solutions
5.2.4 Boehringer Ingelheim Animal Health Veterinary Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Boehringer Ingelheim Animal Health Recent Developments
5.3 Merck Animal Health
5.3.1 Merck Animal Health Profile
5.3.2 Merck Animal Health Main Business
5.3.3 Merck Animal Health Veterinary Drugs Products, Services and Solutions
5.3.4 Merck Animal Health Veterinary Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Elanco Recent Developments
5.4 Elanco
5.4.1 Elanco Profile
5.4.2 Elanco Main Business
5.4.3 Elanco Veterinary Drugs Products, Services and Solutions
5.4.4 Elanco Veterinary Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Elanco Recent Developments
5.5 Bayer AG
5.5.1 Bayer AG Profile
5.5.2 Bayer AG Main Business
5.5.3 Bayer AG Veterinary Drugs Products, Services and Solutions
5.5.4 Bayer AG Veterinary Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Bayer AG Recent Developments
5.6 Ceva Sante Animale S.A.
5.6.1 Ceva Sante Animale S.A. Profile
5.6.2 Ceva Sante Animale S.A. Main Business
5.6.3 Ceva Sante Animale S.A. Veterinary Drugs Products, Services and Solutions
5.6.4 Ceva Sante Animale S.A. Veterinary Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Ceva Sante Animale S.A. Recent Developments
5.7 Virbac SA
5.7.1 Virbac SA Profile
5.7.2 Virbac SA Main Business
5.7.3 Virbac SA Veterinary Drugs Products, Services and Solutions
5.7.4 Virbac SA Veterinary Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Virbac SA Recent Developments
5.8 Vetoquinol SA
5.8.1 Vetoquinol SA Profile
5.8.2 Vetoquinol SA Main Business
5.8.3 Vetoquinol SA Veterinary Drugs Products, Services and Solutions
5.8.4 Vetoquinol SA Veterinary Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Vetoquinol SA Recent Developments
5.9 IDEXX Laboratories, Inc.
5.9.1 IDEXX Laboratories, Inc. Profile
5.9.2 IDEXX Laboratories, Inc. Main Business
5.9.3 IDEXX Laboratories, Inc. Veterinary Drugs Products, Services and Solutions
5.9.4 IDEXX Laboratories, Inc. Veterinary Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 IDEXX Laboratories, Inc. Recent Developments
5.10 Covetrus, Inc.
5.10.1 Covetrus, Inc. Profile
5.10.2 Covetrus, Inc. Main Business
5.10.3 Covetrus, Inc. Veterinary Drugs Products, Services and Solutions
5.10.4 Covetrus, Inc. Veterinary Drugs Revenue (US$ Million) & (2018-2023)
5.10.5 Covetrus, Inc. Recent Developments
6 North America
6.1 North America Veterinary Drugs Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Veterinary Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Veterinary Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Veterinary Drugs Market Dynamics
11.1 Veterinary Drugs Industry Trends
11.2 Veterinary Drugs Market Drivers
11.3 Veterinary Drugs Market Challenges
11.4 Veterinary Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
